Author: Tom Wilemon
Eden Biltibo is Multiple Myeloma Research Foundation scholar recipient
Dec. 5, 2023—Vanderbilt’s Eden Biltibo, MD, MS, is one of the first recipients of the Multiple Myeloma Research Foundation’s Scholars Program, an initiative launched in 2022.
Ukrainian oncologists visit Vanderbilt-Ingram Cancer Center
Nov. 30, 2023—A group of Ukrainian oncologists recently visited Vanderbilt-Ingram Cancer Center where they toured research labs, observed tumor board meetings, met with several Vanderbilt oncologists, and attended the 23rd Annual Retreat for Cancer Biology.
Debra Friedman named deputy director of Vanderbilt-Ingram Cancer Center
Oct. 26, 2023—Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center earns NCI Merit Award
Oct. 17, 2023—Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.
Prostate cancer survivors symposium set for Nov. 11
Oct. 12, 2023—Vanderbilt University Medical Center Department of Urology and Vanderbilt-Ingram Cancer Center are hosting a symposium for prostate cancer survivors and their families on Saturday, Nov. 11.
Symposium for patients, caregivers and family members offers important information on stomach cancer, Nov. 4
Oct. 12, 2023—A Vanderbilt symposium on Nov. 4 offers detailed information for patients, caregivers and family members about stomach cancer.
Study validates pyrvinium as treatment to prevent stomach cancer
Oct. 5, 2023—A Vanderbilt study found that a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.
Vulnerability found in immunotherapy-resistant triple-negative breast cancer
Oct. 4, 2023—Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.
Study finds new genetic susceptibilities for colon cancer
Sep. 12, 2023—Vanderbilt researchers at have found new genes that put people at higher risk for colon cancer and rectal cancer.
Foundation funds research to block drug resistance in cancer treatment
Sep. 1, 2023—The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.
Vanderbilt-Ingram Cancer Center hosts Korean American Symposium
Aug. 17, 2023—Vanderbilt-Ingram Cancer Center recently hosted the first of a planned series of events to highlight the diversity of oncology researchers and to nurture networking opportunities for them.
New leaders named to Vanderbilt-Ingram research programs
Aug. 10, 2023—Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.
